封面
市场调查报告书
商品编码
1750688

医药分析测试外包市场规模、份额、趋势分析报告:按服务、最终用途、地区、细分市场预测,2025-2030 年

Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Service, By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

医药分析和测试外包市场的成长和趋势

预计到 2030 年,全球医药分析测试外包市场规模将达到 145.6 亿美元,2025 年至 2030 年的复合年增长率为 8.6%。

生物候选化合物的不断增加、对药物深度分析的需求日益增长以及监管机构的製程开发,正在推动市场的成长。分析测试不仅有助于即时产品品管,还有助于製程优化和监控,从而识别不同的药物。多年来,临床试验的数量一直持续增加。

例如,2021 年在 ClinicalTrial.gov 上註册的临床试验超过 399,525 项,但截至 2022 年 6 月,这一数字已增至 421,258 多项。预计这种趋势的延续即使在疫情过后也将对市场产生正面影响。大多数中小型製药公司缺乏分析测试的基础设施。因此,将这些业务外包已成为最佳选择,因为它可以节省时间和金钱。主要针对小分子和生技药品的专利悬崖可能会促进对市售学名药的分析测试,这将增加医药市场上上市药品的数量,从而对市场产生积极影响。

自新冠疫情以来,多种疾病的发生率上升。例如,儿童国家医院儿科研究与临床创新中心发布的一份报告调查了737名确诊患有糖尿病的青少年,发现在2018年3月11日至2021年3月10日期间,儿童1型糖尿病(T1D)的发病率增加了15.2%,2型糖尿病(T2D)的发病率增加了182%。疾病盛行率的上升预计将促进药品生产,并可能推动对非处方药分析服务的需求。

药品分析测试外包市场报告重点

  • 生物分析测试领域将占据市场主导地位,2024 年的收入份额将达到 38.44%。生物分析测试包括临床测试和非临床测试。
  • 2024 年,製药业占据了最大的市场占有率。製药公司对核心竞争力的关注度不断提高,这是该行业占最大份额的主要原因之一。
  • 由于北美地区拥有大量製药公司,预计该地区将占据最大的收益占有率,为 52.91%。
  • 预计亚太地区将成为2025年至2030年间成长最快的区域市场,这得归功于第三方服务供应商提供的低成本服务。

目录

第一章调查方法与范围

第二章执行摘要

第三章。医药分析测试外包市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 临床试验量分析(2024年)
    • 各地区临床试验总数
    • 各阶段临床试验总数
    • 按研究设计分類的临床试验总数
    • 按主要治疗领域分類的临床试验总数
  • 定价模式分析
  • 科技
  • 市场分析工具
    • 波特五力分析
    • PESTEL 与 SWOT 分析
    • COVID-19影响分析

第四章:医药分析和测试外包市场:按服务分類的估计和趋势分析

  • 医药分析测试外包市场(按服务):细分仪表板
  • 医药分析测试外包市场(按服务):波动分析
  • 按服务分类,2018-2030 年
  • 生物分析测试
    • 临床
    • 非临床
  • 方法开发和检验
    • 可萃取与可浸出
    • 杂质法
    • 技术咨询
    • 其他的
  • 稳定性测试
    • 药物成分
    • 稳定性指标检验
    • 加速稳定性试验
    • 光稳定性测试
    • 其他的
  • 其他的

第五章。医药分析测试外包市场:按最终用途的估计和趋势分析

  • 医药分析测试外包市场(依最终用途):细分仪表板
  • 医药分析测试外包市场,依最终用途:变异分析
  • 依最终用途,2018-2030 年
  • 製药公司
  • 生物製药公司
  • 合约研究组织

第六章:医药分析和测试外包市场:按地区估计和趋势分析

  • 区域市场仪表板
  • 2024 年及 2030 年区域市场占有率分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 泰国
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争态势

  • 市场参与企业分类
  • 2024 年公司市场占有率/估值分析
  • 公司简介
    • SGS Societe Generale de Surveillance SA
    • Labcorp
    • Eurofins Scientific
    • Pace Analytical Services LLC
    • Intertek Group plc
    • PPD Inc(Thermo Fisher Scientific Inc.)
    • Wuxi AppTec
    • BA Sciences
    • Charles River Laboratories
    • West Pharmaceutical Services, Inc
Product Code: GVR-1-68038-365-2

Pharmaceutical Analytical Testing Outsourcing Market Growth & Trends:

The global pharmaceutical analytical testing outsourcing market size is estimated to reach USD 14.56 billion by 2030 and is projected to grow at a CAGR of 8.6% from 2025 to 2030. Increasing biological candidate pipelines, rising demand for additional analytical details on drugs, and process development by regulatory agencies are driving market growth. Analytical testing aids in real-time product quality control as well as help optimize and monitor processes, thereby identifying different drugs. Over the years, the number of clinical trials has increased consistently.

For instance, in 2021, over 399,525 clinical studies were registered on ClinicalTrial.gov, whereas as of June 2022, it had increased to over 421,258 studies. A continuation of this trend is expected to have a positive impact on the market in the post-pandemic period. The majority of small and medium-sized pharma companies lack the infrastructure for analytical testing. As a result, outsourcing these operations is the best option as it saves time and money. The patent cliff, primarily for small molecules and biologics, is likely to have a positive impact on the market as it will increase the number of commercial drugs in the pharma market, thus promoting the analytical testing of commercially available generic drugs.

There has been a rise in several diseases post-COVID-19. For instance, according to a report published by Children's National Hospital- pediatric research and clinical innovations center, a study was performed on 737 youths who were diagnosed with diabetes, and it found an increased incidence of pediatric Type 1 Diabetes (T1D) by 15.2% and Type 2 Diabetes (T2D) increased by 182% between March 11, 2018, and March 10, 2021. The rise in disease incidence is expected to improve, drug production, which is likely to drive the demand for analytical services for commercial drugs .

Pharmaceutical Analytical Testing Outsourcing Market Report Highlights:

  • The bioanalytical testing segment dominated the market, accounting for a revenue share of 38.44% in 2024. Bioanalytical testing covers both clinical and non-clinical studies.
  • The pharmaceutical segment gained the largest market share in 2024. The growing demand among pharmaceutical companies to focus on their core competencies is one of the major reasons for the largest segment share.
  • North America is expected to hold the largest revenue share of 52.91% owing to the presence of a significant number of pharmaceutical companies in the region.
  • Asia Pacific is anticipated to be the fastest-growing regional market from 2025 to 2030 due to the low-cost service offerings by third-party service providers in the region.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Pharmaceutical Analytical Testing Outsourcing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Clinical Trials Volume Analysis, (2024)
    • 3.3.1. Total Number Of Clinical Trials By Region
    • 3.3.2. Total Number Of Clinical Trials, By Phase
    • 3.3.3. Total Number Of Clinical Trials, By Study Design
    • 3.3.4. Total Number Of Clinical Trials, By Key Therapeutic Area
  • 3.4. Pricing Model Analysis
  • 3.5. Technology Landscape
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Force Analysis
    • 3.6.2. PESTEL by SWOT Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Pharmaceutical Analytical Testing Outsourcing Market: Service Estimates & Trend Analysis

  • 4.1. Pharmaceutical Analytical Testing Outsourcing Market, By Service: Segment Dashboard
  • 4.2. Pharmaceutical Analytical Testing Outsourcing Market, By Service: Movement Analysis
  • 4.3. Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, By Service, 2018 - 2030 (USD Million)
  • 4.4. Bioanalytical Testing
    • 4.4.1. Bioanalytical Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Clinical
      • 4.4.2.1. Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Non-Clinical
      • 4.4.3.1. Non-Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Method Development & Validation
    • 4.5.1. Method Development & Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Extractable & Leachable
      • 4.5.2.1. Extractable & Leachable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Impurity Method
      • 4.5.3.1. Impurity Method Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Technical Consulting
      • 4.5.4.1. Technical Consulting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Stability Testing
    • 4.6.1. Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Drug Substance
      • 4.6.2.1. Drug Substance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Stability Indicating Method Validation
      • 4.6.3.1. Stability Indicating Method Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.4. Accelerated Stability Testing
      • 4.6.4.1. Accelerated Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.5. Photostability Testing
      • 4.6.5.1. Photostability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.6. Others
      • 4.6.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pharmaceutical Analytical Testing Outsourcing Market: End Use Estimates & Trend Analysis

  • 5.1. Pharmaceutical Analytical Testing Outsourcing Market, By End Use: Segment Dashboard
  • 5.2. Pharmaceutical Analytical Testing Outsourcing Market, By End Use: Movement Analysis
  • 5.3. Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
  • 5.4. Pharmaceutical Companies
    • 5.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Biopharmaceutical Companies
    • 5.5.1. Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Contract Research Organizations
    • 5.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pharmaceutical Analytical Testing Outsourcing Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. North America
    • 6.3.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. U.S
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. Regulatory Framework
      • 6.4.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key Country Dynamics
      • 6.4.9.2. Competitive Scenario
      • 6.4.9.3. Regulatory Framework
      • 6.4.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. China
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Australia
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Company Market Share/Assessment Analysis, 2024
  • 7.3. Company Profiles
    • 7.3.1. SGS Societe Generale de Surveillance SA
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Service Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Labcorp
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Service Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Eurofins Scientific
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Service Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. Pace Analytical Services LLC
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Service Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Intertek Group plc
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Service Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. PPD Inc (Thermo Fisher Scientific Inc.)
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Service Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Wuxi AppTec
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Service Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. BA Sciences
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Service Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. Charles River Laboratories
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Service Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. West Pharmaceutical Services, Inc
      • 7.3.10.1. Company Overview
      • 7.3.10.2. Financial Performance
      • 7.3.10.3. Service Benchmarking
      • 7.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 4 Global Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 5 Global Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
  • Table 6 North America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 8 North America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 9 U.S. Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 10 U.S. Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 11 Canada Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 12 Canada Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 13 Mexico Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 14 Mexico Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 15 Europe Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 16 Europe Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 17 Europe Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 18 UK Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 19 UK Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Germany Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 21 Germany Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 22 France Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 23 France Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 24 Italy Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 25 Italy Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 26 Spain Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 27 Spain Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 28 Denmark Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 29 Denmark Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 30 Sweden Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 31 Sweden Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 32 Norway Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 33 Norway Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 37 Japan Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 38 Japan Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 39 China Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 40 China Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 41 India Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 42 India Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 43 Thailand Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 44 Thailand Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 45 South Korea Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 46 South Korea Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 47 Australia Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 48 Australia Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 49 Latin America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 50 Latin America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 51 Latin America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 52 Brazil Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 53 Brazil Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 54 Argentina Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 55 Argentina Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 59 South Africa Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 60 South Africa Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 63 UAE Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 64 UAE Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 65 Kuwait Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 66 Kuwait Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Pharmaceutical Analytical Testing Outsourcing Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Pharmaceutical Analytical Testing Outsourcing Market: Service outlook and key takeaways
  • Fig. 20 Pharmaceutical Analytical Testing Outsourcing Market: Service movement analysis
  • Fig. 21 Bioanalytical Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Non-Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Method Development & Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Extractable & Leachable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Impurity Method Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Technical Consulting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Drug Substance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Stability Indicating Method Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Accelerated Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Photostability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Others Service Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Pharmaceutical Analytical Testing Outsourcing Market: End Use outlook and key takeaways
  • Fig. 37 Pharmaceutical Analytical Testing Outsourcing Market: End Use movement analysis
  • Fig. 38 Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Contract Research Organizations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Regional Marketplace: Key Takeaways
  • Fig. 42 North America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018-2030 (USD Million)
  • Fig. 43 Key Country Dynamics
  • Fig. 44 U.S. Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key Country Dynamics
  • Fig. 46 Canada Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key Country Dynamics
  • Fig. 48 Mexico Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Europe Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key Country Dynamics
  • Fig. 51 UK Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key Country Dynamics
  • Fig. 53 Germany Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key Country Dynamics
  • Fig. 55 France Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key Country Dynamics
  • Fig. 57 Italy Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key Country Dynamics
  • Fig. 59 Spain Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key Country Dynamics
  • Fig. 61 Denmark Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key Country Dynamics
  • Fig. 63 Sweden Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key Country Dynamics
  • Fig. 65 Norway Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key Country Dynamics
  • Fig. 67 Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key Country Dynamics
  • Fig. 69 Japan Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key Country Dynamics
  • Fig. 71 China Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key Country Dynamics
  • Fig. 73 India Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key Country Dynamics
  • Fig. 75 Thailand Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key Country Dynamics
  • Fig. 77 South Korea Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key Country Dynamics
  • Fig. 79 Australia Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Latin America Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key Country Dynamics
  • Fig. 82 Brazil Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key Country Dynamics
  • Fig. 84 Argentina Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 MEA Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key Country Dynamics
  • Fig. 87 South Africa Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key Country Dynamics
  • Fig. 89 Saudi Arabia Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key Country Dynamics
  • Fig. 91 UAE Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key Country Dynamics
  • Fig. 93 Kuwait Pharmaceutical Analytical Testing Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key company categorization
  • Fig. 95 Service heat map analysis
  • Fig. 96 Strategic framework